{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:50:28Z","timestamp":1791049828088,"version":"4.1.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,10,14]],"date-time":"2008-10-14T00:00:00Z","timestamp":1223942400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1038\/ncpneuro0936","type":"journal-article","created":{"date-parts":[[2008,10,14]],"date-time":"2008-10-14T10:57:19Z","timestamp":1223981839000},"page":"594-595","source":"Crossref","is-referenced-by-count":23,"title":["Duloxetine and pregabalin: safe and effective for the long-term treatment of fibromyalgia?"],"prefix":"10.1038","volume":"4","author":[{"given":"Eric","family":"Serra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,14]]},"reference":[{"key":"BFncpneuro0936_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F  et al. (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33: 160\u2013172","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"BFncpneuro0936_CR2","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1002\/hup.622","volume":"19","author":"O Vitton","year":"2004","unstructured":"Vitton O  et al. (2004) A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 19 (Suppl 1): S27\u2013S35","journal-title":"Hum Psychopharmacol"},{"key":"BFncpneuro0936_CR3","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/art.20485","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold LM  et al. (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depression disorder. Arthritis Rheum 50: 2974\u20132984","journal-title":"Arthritis Rheum"},{"key":"BFncpneuro0936_CR4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/art.20983","volume":"52","author":"LJ Crofford","year":"2005","unstructured":"Crofford LJ  et al. (2005) Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52: 1264\u20131273","journal-title":"Arthritis Rheum"},{"key":"BFncpneuro0936_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","volume":"136","author":"IJ Russell","year":"2008","unstructured":"Russell IJ  et al. (2008) Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 136: 432\u2013444","journal-title":"Pain"},{"key":"BFncpneuro0936_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.pain.2008.02.027","volume":"136","author":"LJ Crofford","year":"2008","unstructured":"Crofford LJ  et al. (2008) Fibromyalgia relapse evaluation and efficacy for durability on meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 136: 419\u2013431","journal-title":"Pain"},{"key":"BFncpneuro0936_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","volume":"37","author":"MB Yunus","year":"2007","unstructured":"Yunus MB (2007) Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 37: 339\u2013352","journal-title":"Semin Arthritis Rheum"},{"key":"BFncpneuro0936_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/ard.2007.071522","volume":"67","author":"SF Carville","year":"2007","unstructured":"Carville SF  et al. (2007) EULAR evidence based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67: 536\u2013541","journal-title":"Ann Rheum Dis"}],"container-title":["Nature Clinical Practice Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0936","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:34:28Z","timestamp":1684442068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,14]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["BFncpneuro0936"],"URL":"https:\/\/doi.org\/10.1038\/ncpneuro0936","relation":{},"ISSN":["1745-834X","1745-8358"],"issn-type":[{"value":"1745-834X","type":"print"},{"value":"1745-8358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,14]]}}}